The coronavirus disease 2019 (COVID‐19) is a lung infection that in its most severe manifestations leads to ischemic, thrombotic and respiratory complications that can increase mortality and intensive care admission. In the early phase of pandemic infection, we assessed the relationship between conjunctivitis and COVID-19. Interestingly, we found an association between COVID-19 severe disease and an increased incidence of conjunctivitis. However, the meta-analysis was limited by the low rate of events and by the population composed exclusively by Chinese COVID-19 patients. Thus, after almost 2 years of pandemic, the goal of this meta-analysis is to assess whether the association with COVID-19 severity persists in a larger number of patients with conjunctivitis and different ethnicities. As eligibility criteria we assessed the following types of studies: clinical studies in hospitalized patients with COVID-19 infection that assessed the severe (as severe pneumonia, mortality, ARDS, and use of mechanical ventilation or ICU recovery) and non-severe forms of the disease and reported the incidence of conjunctivitis.

Different rates of conjunctivitis in COVID-19 eastern and western hospitalized patients: a meta-analysis / Loffredo, L.; Fallarino, A.; Paraninfi, A.; Pacella, F.; Pacella, E.; Oliva, A.; Violi, F.. - In: INTERNAL AND EMERGENCY MEDICINE. - ISSN 1828-0447. - 17:3(2022), pp. 925-928. [10.1007/s11739-021-02880-z]

Different rates of conjunctivitis in COVID-19 eastern and western hospitalized patients: a meta-analysis

Loffredo L.
Primo
;
Fallarino A.
Secondo
;
Paraninfi A.;Pacella F.;Pacella E.;Oliva A.
Penultimo
;
Violi F.
Ultimo
2022

Abstract

The coronavirus disease 2019 (COVID‐19) is a lung infection that in its most severe manifestations leads to ischemic, thrombotic and respiratory complications that can increase mortality and intensive care admission. In the early phase of pandemic infection, we assessed the relationship between conjunctivitis and COVID-19. Interestingly, we found an association between COVID-19 severe disease and an increased incidence of conjunctivitis. However, the meta-analysis was limited by the low rate of events and by the population composed exclusively by Chinese COVID-19 patients. Thus, after almost 2 years of pandemic, the goal of this meta-analysis is to assess whether the association with COVID-19 severity persists in a larger number of patients with conjunctivitis and different ethnicities. As eligibility criteria we assessed the following types of studies: clinical studies in hospitalized patients with COVID-19 infection that assessed the severe (as severe pneumonia, mortality, ARDS, and use of mechanical ventilation or ICU recovery) and non-severe forms of the disease and reported the incidence of conjunctivitis.
File allegati a questo prodotto
File Dimensione Formato  
Loffredo_Different rates of_2022.pdf

accesso aperto

Note: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575664/
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 580.99 kB
Formato Adobe PDF
580.99 kB Adobe PDF Visualizza/Apri PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1631097
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact